glp-1 receptor agonists side effects Updated Ranking and of When GLP-1 Receptor Agonists as Treatments

doi: 10.1093/EURHEARTJ/EHAA082 119 BatistaAFBodart-SantosVDe FeliceFGFerreiraST

In fact, this could lead to an increased risk of side effects, such as nausea, vomiting, low blood sugar, and other complications

This dual-action approach enhances insulin sensitivity and further reduces appetite and fat storage, often leading to even more substantial weight loss than GLP-1-only therapies

Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials

Pfeffer MA, Claggett B, Diaz R et al (2015) Lixisenatide in patients with type 2 diabetes and acute coronary syndrome

This process entails the adhesion of the peripheral immune cells to endothelial cells, which facilitates their translocation across the blood-brain barrier, ultimately resulting in barrier disruption, cerebral edema, and brain injury, which indirectly promote the infiltration of peripheral immune cells (69)